27/09/2025
**Updated Highlights in Atrial Fibrillation Classification and Management **
**2023–2024 trials**
> Ablation in patients with AF + HFrEF (w/ EF First-line catheter ablation (cryoablation) for symptomatic paroxysmal AF led to greater freedom from atrial arrhythmia recurrence, better symptom control and reduced AF progression vs antiarrhythmic drugs (AADs). Trials support ablation as a first-line option in selected paroxysmal AF patients.
==> AF triggers
* Stress : emotional trigger/Recent **infection**/surgery/**MI/PE**/BS disturbance/**anemia**
* Comorbidity : **Hypertension**/Obesity/DM/**OSA**/HF/Valvular disease/thyroid disease/CKD/Chronic lung disease
* **Lifestyle** : alcohol, caffeine, exercise, smoking
* **Cardiomyopathies**: hypertrophic, restrictive, amyloidosis
==> Complication
* **Stroke or TIA **
* **MI** or **HF**
* **dementia**
**==> AF-CARE approach :**
* **C **omorbidity and Risk Factor Management: The initial and central step, focusing on treating **hypertension**, **heart failure**, **diabetes**, **obesity**, **sleep apnea**, **thyroid** disease, physical activity, and alcohol intake to improve quality of life and outcomes**.**
* **A** ** **void Stroke and Thromboembolism with strong preference for DOAC over warfarin and limitations on dual therapy with antiplatelets.